Sunday, September 13, 2009

Alimta

In a clinical study of 448 patients Alimta

was successful in increasing survival

time of patients by approximately 30%.

Alimta is administered in one ten

minute infusion every three weeks.

It has also shown great results in

conjunction with cisplatin, a standard

chemotherapy drug.

No comments:

Post a Comment